Cleared Special

K011213 - MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM

K011213 is an FDA 510(k) clearance for MODIFICATION TO SYNCHRON LX 20 CLINICAL..., manufactured by Beckman Coulter, Inc.. The device is a Class 2 Chemistry device with product code JGS cleared through the Special 510(k) pathway after a 26-day FDA review.

K011213 · Beckman Coulter, Inc. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2001
Decision
26d
Days
Class 2
Risk

K011213 is an FDA 510(k) clearance for the MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM. Classified as Electrode, Ion Specific, Sodium (product code JGS), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on May 16, 2001 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1665 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K011213

510(k) Number K011213 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 2001
Decision Date May 16, 2001
Days to Decision 26 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 89d · This submission: 26d
Pathway characteristics
Modification to existing cleared device.

JGS Device Classification - Class 2, Special Controls

Product Code JGS Electrode, Ion Specific, Sodium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGS Electrode, Ion Specific, Sodium

All 160
Devices cleared under the same product code (JGS) and FDA review panel - the closest regulatory comparables to K011213.
GENCHEM ISE ELECTROLYTE REFERENCE
K040971 · Genchem, Inc. · Dec 2004
SYNCHRON LX I 725 CLINICAL SYSTEM
K023049 · Beckman Coulter, Inc. · Oct 2002
PHOENIX ISE REAGENTS FOR BECKMAN CX SYSTEMS
K020364 · Phoenix Diagnostics, Inc. · Jun 2002
EASYELECTROLYTE NA/K/LI ANALYZER & RAPIDLYTE NA/K/LI ANALYZER
K002407 · Medica Corp. · Feb 2001
BIOLYTE 2000 NA+,K+,CL-/LI+ELECTROLYTE ANALYZER
K002855 · Biocare Corp. · Oct 2000
STATLYTE NA/K/CL/LI ANALYZER
K001761 · Nova Biomedical Corp. · Aug 2000
K011213 · MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM
Download PDF FDA Summary Beckman Coulter, Inc.